Pharma

Johnson & Johnson company LifeScan is launching a clinical trial to determine whether its OneTouch Verio blood glucose meter (or a not-yet-launched version of it) creates a greater reduction in A1C levels when used in conjunction with its companion app.

A majority of consumers are willing to take greater ownership of their health, according to a survey of 2,024 US adults and 516 primary care physicians.

New Jersey's Division of Consumer Affairs has launched a new app for iPhones that will allow authorized users of the state’s prescription monitoring program, prescribers and pharmacists licensed in New Jersey, access to the database via their smartphone.

Boston-based patient network PatientsLikeMe announced two pieces of pharma news this week: a five-year research collaboration deal with AstraZeneca and the results of a multiple sclerosis wearable study conducted in collaboration with Biogen.

IBM Watson has taken a giant step deeper into the healthcare industry with the formation of a new business unit called Watson Health and a new cloud offering called the Watson Health Cloud.

Since Walgreens merged with UK drugstore chain Boots last year, the company has been ramping up its digital strategy and has announced a slew of strategic partnerships with companies like Qualcomm Life, WebMD, MDLive, and PatientsLikeMe.

In March, Roche received FDA clearance for its Accu-Chek Connect companion app, and, less than a month later, issued a recall of that app.

Vancouver-based Ayogo has raised $2.

When pharma-focused mobile clinical trial data collection company Clinical Ink and CentrosHealth, formerly MyHealthBook, which makes configurable mobile apps for clinical trial patient engagement,merged last month, at least $9.

Misfit Flash, one of the devices that will be used in the study.